Literature DB >> 29335464

Evaluation of endothelial function by VOP and inflammatory biomarkers in patients with arterial hypertension.

Camillo L C Junqueira1, Maria Eliane C Magalhães1, Andréa Araújo Brandão1, Esmeralci Ferreira1, Adriana S M Junqueira1, José Firmino N Neto1, Maria das Graças C Souza1, Daniel Alexandre Bottino2, Eliete Bouskela1.   

Abstract

Hypertension is associated with microcirculatory impairment. Our objectives were to evaluate endothelial function and inflammatory biomarkers in patients with resistant (RH) and mild to moderate (MMH) arterial hypertension in comparison to normotensives (control group-CG). Three groups, 25 patients each, have been investigated, by anamnesis, venous occlusion plethysmography (VOP) and serum determination of adhesion molecules (VCAM, ICAM), adiponectin, endothelin and C-reactive protein (CRP). Patients not using statins and with or without blood pressure control were also analyzed. RH group showed smaller percentage increase of maximum forearm blood flow (FBF) (endothelial-dependent vasodilatation) than controls (p < 0.05), but no significant difference could be detected between MMH and CG groups on maximum FBF and minimum vascular resistance post-ischemia. RH and MMH groups showed higher resistance averages compared to controls (p < 0.05). Uncontrolled BP in hypertensive patients showed worse results for blood flow and resistance. Endothelial-independent vasodilatation was not affected. Endothelin levels were higher in RH and MMH groups (p < 0.05) not using statins. CRP was significantly higher only in RH compared to CG (p < 0.05). In conclusion patients with severe hypertension and lack of blood pressure control showed greater impairment of endothelial function with higher CRP and endothelin levels.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29335464     DOI: 10.1038/s41371-017-0024-z

Source DB:  PubMed          Journal:  J Hum Hypertens        ISSN: 0950-9240            Impact factor:   3.012


  39 in total

Review 1.  Venous occlusion plethysmography in cardiovascular research: methodology and clinical applications.

Authors:  I B Wilkinson; D J Webb
Journal:  Br J Clin Pharmacol       Date:  2001-12       Impact factor: 4.335

2.  [VI Brazilian Guidelines on Hypertension].

Authors: 
Journal:  Arq Bras Cardiol       Date:  2010-07       Impact factor: 2.000

3.  Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events.

Authors:  P M Ridker; N Rifai; M Clearfield; J R Downs; S E Weis; J S Miles; A M Gotto
Journal:  N Engl J Med       Date:  2001-06-28       Impact factor: 91.245

Review 4.  The antihypertensive actions of statins: modulation by salt intake.

Authors:  Luis I Juncos; Luis A Juncos; Nestor H García
Journal:  Am J Hypertens       Date:  2012-07-26       Impact factor: 2.689

5.  Propranolol treatment lowers blood pressure, reduces vascular inflammatory markers and improves endothelial function in obese mice.

Authors:  Nathalia da Silva Franco; Camila Lubaczeuski; Daniele M Guizoni; Jamaira A Victorio; Junia C Santos-Silva; Patricia C Brum; Everardo M Carneiro; Ana P Davel
Journal:  Pharmacol Res       Date:  2017-05-21       Impact factor: 7.658

6.  Rosuvastatin for primary prevention in older persons with elevated C-reactive protein and low to average low-density lipoprotein cholesterol levels: exploratory analysis of a randomized trial.

Authors:  Robert J Glynn; Wolfgang Koenig; Børge G Nordestgaard; James Shepherd; Paul M Ridker
Journal:  Ann Intern Med       Date:  2010-04-20       Impact factor: 25.391

7.  Effect of increased availability of endothelium-derived nitric oxide precursor on endothelium-dependent vascular relaxation in normal subjects and in patients with essential hypertension.

Authors:  J A Panza; P R Casino; D M Badar; A A Quyyumi
Journal:  Circulation       Date:  1993-05       Impact factor: 29.690

8.  C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease.

Authors:  John Danesh; Jeremy G Wheeler; Gideon M Hirschfield; Shinichi Eda; Gudny Eiriksdottir; Ann Rumley; Gordon D O Lowe; Mark B Pepys; Vilmundur Gudnason
Journal:  N Engl J Med       Date:  2004-04-01       Impact factor: 91.245

9.  Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.

Authors: 
Journal:  Lancet       Date:  2014-12-18       Impact factor: 79.321

10.  Amiloride Improves Endothelial Function and Reduces Vascular Stiffness in Female Mice Fed a Western Diet.

Authors:  Luis A Martinez-Lemus; Annayya R Aroor; Francisco I Ramirez-Perez; Guanghong Jia; Javad Habibi; Vincent G DeMarco; Brady Barron; Adam Whaley-Connell; Ravi Nistala; James R Sowers
Journal:  Front Physiol       Date:  2017-06-30       Impact factor: 4.566

View more
  2 in total

Review 1.  Vascular Health Triad in Humans With Hypertension-Not the Usual Suspects.

Authors:  Sushant M Ranadive; Gabrielle A Dillon; Sara E Mascone; Lacy M Alexander
Journal:  Front Physiol       Date:  2021-10-01       Impact factor: 4.566

2.  Neutrophil to Lymphocyte Ratio Is Increased and Associated With Left Ventricular Diastolic Function in Newly Diagnosed Essential Hypertension Children.

Authors:  Miao Hou; Lei Cao; Yueyue Ding; Ye Chen; Bo Wang; Jie Shen; Wanping Zhou; Jie Huang; Qiuqin Xu; Haitao Lv; Ling Sun
Journal:  Front Pediatr       Date:  2021-05-19       Impact factor: 3.418

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.